Back
 

View:
Mini 
BasicThis view is available after user registration.
 
ShortThis view is available when you buy a license.
 
StandardThis view is available when you buy a license.
 
CompleteThis view is available when you buy a license.
 

NLG MCL-2 regimen - Cytarabine 3000 / Rituximab 375, Mantle Cell Lymphoma, cycle 6, younger than 60 years

Protocol-ID: 269 V1.1 (Mini), NLG MCL-2 regimen, C6, CYTA3000/RITU375, under 60

Indication(s)

  • Mantle Cell Lymphoma; ICD-10 C83.1
The publishers and authors assume no liability for the accuracy of the contents. The application is at the own responsibility of the treating physician. ©Onkopti.

Valid since: 06.03.2016